Concentrations of circulating β-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 4, 1998, Pages 499-502

  Kakkanaiah, Vellalore N ^a   Ojo Amaize, Emmanuel A ^a   Peter, James B ^a  

^a Specialty Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MAJOR CLINICAL STUDY; PLASMA; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0031858847     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.4.499-502.1998     Document Type: Article

References (25)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
2. Atchison, R. E., J. Gosling, F. S. Monteclaro, C. Franci, L. Digilio, I. F. Charo, and M. A. Goldsmith. 1996. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274: 1924-1926.
3. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:97-179.
4. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sudroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-832.
5. + T cells. Science 270:1811-1815.
6. Cocchi, F., A. L. DeVico, A. Garzino-Demo, A. Cara, R. C. Gallo, and P. Lusso. 1996. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1244-1247.
7. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gumperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856-1862.
8. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-667.
9. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
10. D'Souza, M. P., and V. A. Harder. 1996. Chemokines and HIV-1 second receptors: confluence of two fields generates optimism in AIDS research. Nat. Med. 2:1293-1300.
11. Hedrick, J. A., and A. Zlotnik. 1996. Chemokines and lymphocyte biology. Curr. Opin. Immunol. 8:343-347.
12. Iuliano, R., G. Forastieri, M. Brizzi, L. Mecocci, F. Mazzotta, and L. Ceccherini-Nelli. 1997. Correlation between plasma HIV-1 RNA levels and the rate of immunologie decline. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:408-414.
13. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. USA 93:14076-14081.
14. Krowka, J. F., M. L. Gesner, M. S. Ascher, and H. W. Sheppard. 1997. Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals. Clin. Immunol. Immunopathol. 85:21-27.
15. Mackewicz, C. E., E. Barker, G. Greco, G. Reyes-Teran, and J. A. Levy. 1997. Do β-chemokines have clinical relevance in HIV infection? J. Clin. Invest. 100:921-930.
16. McKenzie, S. W., G. Dallalio, M. North, P. Frame, and R. T. Means, Jr. 1996. Serum chemokine levels in patients with non-progressing HIV infection. AIDS 10:F29-F33.
17. Moore, J. P. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276:51-52.
18. Murphy, P. M. 1994. The molecular biology of leukocyte chemoaltractant receptors. Annu. Rev. Immunol. 12:593-633.
19. Oberlin, E., A. Amara, F. Bacherlerie, C. Bessia, J.-L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.-M. Heard, I. Clark-Lewis, D. F. Legler, M. Loetscher, M. Baggiolini, and B. Moser. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835.
20. Oravecz, T., M. Pall, and M. A. Norcross. 1996. β-Chemokine inhibition of monocytotropic HIV-1 infection: interference with a postbinding fusion step. J. Immunol. 157:1329-1332.
21. Paxton, W. A., S. R. Martin, D. Tse, T. R. O'Brien, J. Skurnick, N. L. VanDevanter, N. Padian, J. F. Braun, D. P. Kotler, S. M. Wolinsky, and R. A. Koup. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat. Med. 2:412-417.
22. Roederer, M., J. G. Dub, M. T. Anderson, P. A. Raju, L. A. Herzenberg, and L. A. Herzenberg. 1995. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 5:2061-2069.
23. + T cell-mediated suppression of HIV replication; β-chemokine-dependent and -independent effects. AIDS Res. Hum. Retroviruses 13:63-69.
24. Trkola, A., T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR5. Nature 384:184-187.
25. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newmann, C. Gerard, and J. Sodroski. 1996 CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR5. Nature 384:179-183.